Related Experiment Video
Updated: Feb 8, 2026

Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment
Published on: September 25, 2009
Microsurgical treatment of unruptured middle cerebral artery aneurysms: a large, contemporary experience
Eric S Nussbaum1, Michael T Madison1, James K Goddard1
11National Brain Aneurysm Center, Twin Cities, Minnesota; and.
Objective:
Advances in endovascular therapy for the treatment of middle cerebral artery (MCA) aneurysms have led to scrutiny of its benefits compared with microsurgical repair. To provide information regarding complication rates and outcomes, the authors reviewed the results of a large series of unruptured MCA aneurysms treated with open microsurgery.
Methods:
The authors included all patients who underwent surgical repair of an unruptured MCA aneurysm between 1997 and 2015. All surgical procedures, including clipping, wrapping, bypass, and parent artery occlusion, were performed by a single neurosurgeon. Aneurysm occlusion was assessed using intraoperative digital subtraction angiography (DSA) or DSA and indocyanine green videoangiography in all cases. Postoperatively, all patients were monitored in a neurointensive care unit overnight. Clinical follow-up was scheduled for 2-4 weeks after surgery, and angiographic follow-up was performed in those patients with subtotally occluded aneurysms at 1, 2, and 5 years postoperation.
Results:
The authors treated 750 unruptured MCA aneurysms in 716 patients: 649 (86.5%) aneurysms were small, 75 (10.0%) were large, and 26 (3.5%) were giant. Most aneurysms (n = 677, 90%) were treated by primary clip reconstruction. The surgical morbidity rate was 2.8%, and the mortality rate was 0%. Complete angiographic aneurysm occlusion was achieved in 92.0% of aneurysms. At final follow-up, 713 patients had a modified Rankin Scale (mRS) score of 0, 2 patients had an mRS score of 2 or 3, and 1 had an mRS score of 4.
Conclusions:
In high-volume centers, microsurgical management of MCA aneurysms can be performed with very low morbidity rates. Currently, microsurgical repair appears to be a highly effective method of treating MCA aneurysms.
Insights
Microsurgical repair of unruptured middle cerebral artery (MCA) aneurysms demonstrates excellent outcomes. This study found very low complication rates and high success in aneurysm occlusion, supporting microsurgery as a safe and effective treatment option.
Area of Science:
- Neurosurgery
- Vascular Surgery
- Neurology
Background:
- Endovascular therapies for middle cerebral artery (MCA) aneurysms are advancing.
- This necessitates a re-evaluation of microsurgical repair's benefits and outcomes.
- Understanding complication rates is crucial for treatment selection.
Purpose of the Study:
- To review outcomes of open microsurgery for unruptured MCA aneurysms.
- To assess complication rates associated with microsurgical repair.
- To provide data on the efficacy of microsurgical treatment.
Main Methods:
- Retrospective review of 716 patients with 750 unruptured MCA aneurysms treated between 1997 and 2015.
- All procedures performed by a single neurosurgeon using techniques like clipping, wrapping, bypass, and parent artery occlusion.
- Aneurysm occlusion confirmed with intraoperative digital subtraction angiography (DSA) and/or indocyanine green videoangiography.
Main Results:
- A total of 750 unruptured MCA aneurysms were treated, with 90% by primary clip reconstruction.
- Surgical morbidity rate was 2.8%, with a mortality rate of 0%.
- Complete angiographic occlusion was achieved in 92.0% of aneurysms, with most patients having excellent functional outcomes (mRS 0-1).
Conclusions:
- Microsurgical management of MCA aneurysms in high-volume centers yields very low morbidity.
- Microsurgical repair remains a highly effective and safe treatment for MCA aneurysms.
- This approach offers excellent long-term functional outcomes for patients.
Related Concept Videos
Contemporary Psychology
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Aneurysm I: Introduction
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

